Study Links High-Fat Diets to Increased Colorectal Cancer Risk via Gut Bacteria
A team of researchers from the Technical University of Munich, RWTH Aachen, and the German Institute of Human Nutrition Potsdam-Rehbrücke has uncovered a concerning link between high-fat diets, often referred to as Western diets, and the development of colorectal cancer, particularly in adults under 50. Their findings, published in the August 2026 issue of the journal Gut, reveal how such diets can sustain specific gut bacteria that produce a secondary bile acid, which promotes tumor growth.
The lead author of the study, Annika Osswald, a PhD student at the German Institute of Human Nutrition, emphasized the significance of their work in establishing causality. Previously, the connection between certain bile acids and colorectal cancer was known, but this study provides clearer evidence of how dietary fat influences cancer risk.
In the human body, dietary fat triggers the liver to produce primary bile acids, essential for fat digestion. While most of these acids are reabsorbed, a small portion reaches the colon, where certain bacteria convert them into secondary bile acids, notably deoxycholic acid (DCA). The study found that higher consumption of fatty foods correlates with increased levels of DCA in the colon, which is associated with tumor development.
To investigate this further, the researchers conducted experiments using mouse models. They implanted DCA-producing bacteria into mice with controlled intestinal microbiomes and induced colorectal cancer. The results showed that mice harboring DCA-producing bacteria experienced more significant tumor growth compared to those without such bacteria. Increased cell division in these mice suggests a heightened risk of cancer due to potential DNA replication errors.
To ascertain whether these findings were applicable to humans, the team analyzed stool samples from over a thousand individuals, both with and without colorectal cancer. They discovered that genes linked to DCA-producing bacteria were more prevalent in those with the disease, reinforcing the connection between diet, gut microbiome changes, and colorectal health.
Osswald noted that while their study lays foundational work, further research is needed to explore the implications of these findings. The increasing mortality rate from colorectal cancer among individuals under 50, as reported in the Journal of the American Medical Association in January 2026, underscores the urgency of this research. Unlike other cancers, the mortality rate for colorectal cancer in this age group has risen by 1.1% annually since 2005.
Early detection remains a challenge, as symptoms often mimic less severe conditions, leading to potential misdiagnosis. Common symptoms include changes in bowel habits, abdominal discomfort, and unexplained weight loss. The stigma surrounding colorectal health can also deter individuals from discussing symptoms with healthcare providers.
Looking ahead, microbiome transplants may offer a novel approach to managing colorectal cancer. Osswald suggested that transferring the microbiome of individuals with lower levels of DCA-producing bacteria into patients could potentially slow tumor growth. However, prevention remains paramount. While genetic factors play a role, lifestyle choices such as maintaining a healthy diet, reducing meat and fat intake, and avoiding smoking are critical in lowering colorectal cancer risk.




